APA (7th ed.) Citation

Liu, L., Deng, Y., Li, L., Yang, X., Yin, Z., & Lai, Y. (2024). Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis. PLoS ONE, 19(11), 1. https://doi.org/10.1371/journal.pone.0310696

Chicago Style (17th ed.) Citation

Liu, Lingyan, Yongkun Deng, Lei Li, Xingbiao Yang, Zhaoheng Yin, and Yong Lai. "Efficacy and Safety of Moderate-intensity Rosuvastatin Plus Ezetimibe Versus High-intensity Rosuvastatin Monotherapy in the Treatment of Composite Cardiovascular Events with Hypercholesterolemia: A Meta-analysis." PLoS ONE 19, no. 11 (2024): 1. https://doi.org/10.1371/journal.pone.0310696.

MLA (9th ed.) Citation

Liu, Lingyan, et al. "Efficacy and Safety of Moderate-intensity Rosuvastatin Plus Ezetimibe Versus High-intensity Rosuvastatin Monotherapy in the Treatment of Composite Cardiovascular Events with Hypercholesterolemia: A Meta-analysis." PLoS ONE, vol. 19, no. 11, 2024, p. 1, https://doi.org/10.1371/journal.pone.0310696.